Inorganic Boron Active Ingredients TRIZ Cases

Sodium borates suppress key non-alcoholic fatty liver pathway genes to treat fatty liver with lower side-effect risk.

An in-vitro osteoblast model uses hydroxyurea and boric acid to study brittle bone disease while avoiding ethical limits of human studies.

Limited renal cancer chemotherapy efficacy motivates this case, which uses sodium pentaborate pentahydrate to reduce cell viability and slow proliferation.

Redox-active esters, bis(pinacolato)diboron, and Cu or Ni catalysts convert carboxylic acids to boronic compounds under mild, selective conditions.

Combining sodium pentaborate, curcumin, and piperine targets multiple pathways in hepatocellular carcinoma to limit resistance and toxicity.

A multicomponent pharmaceutical composition stabilizes vascular patterns and reduces inflammation through synergistic vasoconstriction.

TREM2 agonist compounds activate microglial receptors to promote apoptotic cell phagocytosis and enhance amyloid beta clearance in the central nervous system.

A peptide-BSH complex enhances boron delivery to cancer cells through self-assembled spherical structures.

Director elements in bioactive glass alter reaction pathways to form resorbable calcite instead of slow-resorbing hydroxyapatite.

Irreversible covalent binding of novel estrogen receptor antagonists blocks proliferation in resistant ER-positive breast cancer cell lines.

Benzethonium chloride in the gel matrix inhibits microbial growth, resolving skin contamination risks during transcutaneous electrical nerve stimulation.

Ultrasonic emulsification in an inert gas environment reduces toxicity while enhancing treatment efficiency for cancer, diabetes, and Alzheimer's disease.

A synergistic lotion combines D-Panthenol, Niacinamide, and Tea tree oil to target acne bacteria.

Downdrawing a modified vitreous composition produces continuous bioactive fibers suitable for medical fabrics.

Cross-linked acrylic polymers combined with boric acid create a stable topical gel for treating skin infections.

A glycerol and sodium pentaborate formulation creates a biocompatible layer on tissue surfaces to prevent postoperative adhesions.

Tailored phospholipid profiles restore mitochondrial function and reduce oxidative stress damage.

IDO inhibitors block tryptophan depletion to reduce systemic inflammation and enhance antiretroviral therapy efficacy.

A mineral composition using humic shale and apple extract increases ATP levels in skeletal muscle tissue while preventing hydrolysis degradation.

Borate glass scaffolds release copper and zinc to promote blood vessel growth while maintaining structural integrity during biodegradation.

Perborate salts reduce gene expression in cancer cells, lowering proliferation and metastasis while sparing healthy tissue.

Bioactive glass elevates pH and osmotic pressure via ion release to inhibit bacterial growth in bone infections.

Borate glass scaffold prevents unwanted hydroxyapatite formation and immune responses while promoting vascularization and bone density.